Influence of Pro-Qura-generated Plans on Postimplant Dosimetric Quality: A Review of a Multi-Institutional Database
- Wheeling Hospital, Schiffler Cancer Center, Wheeling, WV (United States)
The influence of Pro-Qura-generated plans vs. community-generated plans on postprostate brachytherapy dosimetric quality was compared. In the Pro-Qura database, 2933 postplans were evaluated from 57 institutions. A total of 1803 plans were generated by Pro-Qura and 1130 by community institutions. Iodine-125 ({sup 125}I) plans outnumbered Palladium 103 ({sup 103}Pd) plans by a ratio of 3:1. Postimplant dosimetry was performed in a standardized fashion by overlapping the preimplant ultrasound and the postimplant computed tomography (CT). In this analysis, adequacy was defined as a V{sub 100} > 80% and a D{sub 90} of 90% to 140% for both isotopes along with a V{sub 150} < 60% for {sup 125}I and < 75% for {sup 103}Pd. The mean postimplant V{sub 100} and D{sub 90} were 88.6% and 101.6% vs. 89.3% and 102.3% for Pro-Qura and community plans, respectively. When analyzed in terms of the first 8 sequence groups (10 patients/sequence group) for each institution, Pro-Qura planning resulted in less postimplant variability for V{sub 100} (86.2-89.5%) and for D{sub 90} (97.4-103.2%) while community-generated plans had greater V{sub 100} (85.3-91.2%) and D{sub 90} (95.9-105.2%) ranges. In terms of sequence groups, postimplant dosimetry was deemed 'too cool' in 11% to 30% of cases and 'too hot' in 12% to 27%. On average, no clinically significant postimplant dosimetric differences were discerned between Pro-Qura and community-based planning. However, substantially greater variability was identified in the community-based plan cohort. It is possible that the Pro-Qura plan and/or the routine postimplant dosimetric evaluation may have influenced dosimetric outcomes at community-based centers.
- OSTI ID:
- 21140788
- Journal Information:
- Medical Dosimetry, Vol. 33, Issue 3; Other Information: DOI: 10.1016/j.meddos.2007.09.001; PII: S0958-3947(07)00159-8; Copyright (c) 2008 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0958-3947
- Country of Publication:
- United States
- Language:
- English
Similar Records
A comparison of postimplant dosimetry for {sup 103}Pd versus {sup 131}Cs seeds on a retrospective series of PBSI patients
Effect of Edema on Postimplant Dosimetry in Prostate Brachytherapy Using CT/MRI Fusion